{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:09:21Z","timestamp":1794366561638,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Healthy Ireland"},{"name":"Saolta hospital Group"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Excess adiposity is associated with fat accumulation within the liver, and non-alcoholic steatohepatitis (NASH) is highly prevalent in bariatric patients. Elevated alanine aminotransferase (ALT) is associated with prevalent NASH. We sought to determine the influence of a milk-based meal replacement weight-loss programme on ALT levels in adults with severe and complicated obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of patients who completed a 24-week meal replacement programme, comprised of a weight loss phase followed by weight stabilisation and maintenance phases, each 8\u00a0weeks long. ALT was quantified using an enzymatic assay with spectrophotometric detection. We examined changes over time in ALT using the non-parametric Wilcoxon singed-rank test and the Friedman test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 105 patients, 56 were female, mean age was 51.2\u2009\u00b1\u200911.2 (range 18.0\u201371.6) years. There was an unanticipated but transient increase in ALT from 28.0 [20.0, 40.5]\u00a0iu\/L at baseline to 40.0 [26.0, 55.0]\u00a0iu\/L after 2\u00a0weeks (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0005), followed by a gradual reduction to 21.0 [17.0, 28.3]\u00a0iu\/L by 24\u00a0weeks (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0005). The overall reductions in ALT were more pronounced in patients who had elevated levels at baseline. Body weight decreased from 144.2\u2009\u00b1\u200928.0\u00a0kg at baseline to 121.6\u2009\u00b1\u200925.4\u00a0kg at 24\u00a0weeks (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0005) and body mass index (BMI) decreased from 50.7\u2009\u00b1\u20098.1\u00a0kg\u00a0m\n                      <jats:sup>\u22122<\/jats:sup>\n                      at baseline to 43.0\u2009\u00b1\u20097.6\u00a0kg\u00a0m\n                      <jats:sup>\u22122<\/jats:sup>\n                      by 24\u00a0weeks (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In adults with severe and complicated obesity undergoing a milk-based meal replacement programme, there was an initial unanticipated rise in ALT in the first 2\u00a0weeks, followed by a gradual overall reduction by 24\u00a0weeks. These findings suggest that rapid weight loss secondary to significant caloric restriction might induce a transient deterioration in hepatic steatosis prior to an ultimate overall improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12986-020-00512-5","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T05:03:30Z","timestamp":1602824610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programme"],"prefix":"10.1186","volume":"17","author":[{"given":"Razk","family":"Abdalgwad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Faraz","family":"Rafey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"Ioana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Mary","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek Timothy","family":"O\u2019Keeffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-7090","authenticated-orcid":false,"given":"Francis Martin","family":"Finucane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"512_CR1","first-page":"132","volume":"106","author":"CF Liu","year":"2018","unstructured":"Liu CF, et al. The associations between liver enzymes and the risk of metabolic syndrome in the elderly. ExpGerontol. 2018;106:132\u20136.","journal-title":"ExpGerontol"},{"key":"512_CR2","unstructured":"Ferrier DR, Harvey RA. Lippincott\u2019s illustrated reviews: biochemistry. Philadelphia (USA): Wolters Kluwer Health; 2014."},{"key":"512_CR3","volume-title":"Liver disease and laboratory medicine","author":"I MacFarlane","year":"2000","unstructured":"MacFarlane I, Bomford A, Sherwood R. Liver disease and laboratory medicine. London: ACB Venture Publications; 2000."},{"key":"512_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.aohep.2019.03.006","volume":"18","author":"S Zelber-Sagi","year":"2019","unstructured":"Zelber-Sagi S, et al. Low serum vitamin D is independently associated with unexplained elevated ALT only among non-obese men in the general population. Ann Hepatol. 2019;18:578\u201384.","journal-title":"Ann Hepatol"},{"issue":"1","key":"512_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jhep.2011.03.020","volume":"56","author":"MJ Armstrong","year":"2012","unstructured":"Armstrong MJ, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol. 2012;56(1):234\u201340.","journal-title":"J Hepatol"},{"key":"512_CR6","volume-title":"Tietz textbook of clinical chemistry and molecular diagnostics-e-book","author":"CA Burtis","year":"2012","unstructured":"Burtis CA, Ashwood ER, Bruns DE. Tietz textbook of clinical chemistry and molecular diagnostics-e-book. Amsterdam: Elsevier Health Sciences; 2012."},{"issue":"2","key":"512_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","volume":"20","author":"M Sayiner","year":"2016","unstructured":"Sayiner M, et al. Epidemiology of nonalcoholic fatty liver disease and nonalcoholicsteatohepatitis in the United States and the rest of the world. Clin Liver Dis. 2016;20(2):205\u201314.","journal-title":"Clin Liver Dis"},{"issue":"16","key":"512_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","volume":"9","author":"M Benedict","year":"2017","unstructured":"Benedict M, Zhang X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol. 2017;9(16):715.","journal-title":"World J Hepatol"},{"issue":"12","key":"512_CR9","first-page":"2280","volume":"25","author":"G Bower","year":"2015","unstructured":"Bower G, et al. Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. ObesSurg. 2015;25(12):2280\u20139.","journal-title":"ObesSurg"},{"issue":"Suppl","key":"512_CR10","first-page":"S186","volume":"17","author":"P Angulo","year":"2002","unstructured":"Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J GastroenterolHepatol. 2002;17(Suppl):S186\u201390.","journal-title":"J GastroenterolHepatol"},{"issue":"1","key":"512_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2001.25540","volume":"121","author":"JB Dixon","year":"2001","unstructured":"Dixon JB, Bhathal PS, O\u2019Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholicsteatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121(1):91\u2013100.","journal-title":"Gastroenterology"},{"issue":"11\u201312","key":"512_CR12","first-page":"907","volume":"24","author":"R Gupta","year":"2011","unstructured":"Gupta R, et al. The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children. J PediatrEndocrinolMetab. 2011;24(11\u201312):907\u201311.","journal-title":"J PediatrEndocrinolMetab"},{"issue":"6","key":"512_CR13","first-page":"413","volume":"13","author":"DA de Luis","year":"2009","unstructured":"de Luis DA, et al. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients. Eur Rev Med PharmacolSci. 2009;13(6):413\u20138.","journal-title":"Eur Rev Med PharmacolSci"},{"issue":"11","key":"512_CR14","first-page":"2078","volume":"25","author":"P Praveenraj","year":"2015","unstructured":"Praveenraj P, et al. Prevalence and predictors of non-alcoholic fatty liver disease in morbidly obese south Indian patients undergoing bariatric surgery. ObesSurg. 2015;25(11):2078\u201387.","journal-title":"ObesSurg"},{"issue":"2","key":"512_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","volume":"149","author":"G Lassailly","year":"2015","unstructured":"Lassailly G, et al. Bariatric surgery reduces features of nonalcoholicsteatohepatitis in morbidly obese patients. Gastroenterology. 2015;149(2):379\u201388.","journal-title":"Gastroenterology"},{"issue":"2","key":"512_CR16","first-page":"175","volume":"14","author":"H Spivak","year":"2018","unstructured":"Spivak H, et al. Omega-loop gastric bypass is more effective for weight loss but negatively impacts liver enzymes: a registry-based comprehensive first-year analysis. SurgObesRelat Dis. 2018;14(2):175\u201380.","journal-title":"SurgObesRelat Dis"},{"issue":"3","key":"512_CR17","first-page":"812","volume":"28","author":"M Eilenberg","year":"2018","unstructured":"Eilenberg M, et al. Significant liver-related morbidity after bariatric surgery and its reversal-a case series. ObesSurg. 2018;28(3):812\u20139.","journal-title":"ObesSurg"},{"issue":"7","key":"512_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/MEG.0000000000001135","volume":"30","author":"TT Zou","year":"2018","unstructured":"Zou TT, et al. Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis. Eur J GastroenterolHepatol. 2018;30(7):747\u201355.","journal-title":"Eur J GastroenterolHepatol"},{"issue":"10","key":"512_CR19","first-page":"1398","volume":"14","author":"LA Orci","year":"2016","unstructured":"Orci LA, et al. Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. ClinGastroenterolHepatol. 2016;14(10):1398\u2013411.","journal-title":"ClinGastroenterolHepatol"},{"issue":"4","key":"512_CR20","first-page":"1109","volume":"28","author":"KJP Schwenger","year":"2018","unstructured":"Schwenger KJP, et al. Non-alcoholic fatty liver disease in morbidly obese individuals undergoing bariatric surgery: prevalence and effect of the pre-bariatric very low calorie diet. ObesSurg. 2018;28(4):1109\u201316.","journal-title":"ObesSurg"},{"key":"512_CR21","first-page":"197","volume":"13","author":"MF Rafey","year":"2020","unstructured":"Rafey MF, et al. Effects of a milk-based meal replacement program on weight and metabolic characteristics in adults with severe obesity. Diabetes MetabSyndrObes. 2020;13:197\u2013205.","journal-title":"Diabetes MetabSyndrObes"},{"issue":"9","key":"512_CR22","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/oby.20824","volume":"22","author":"EA Finkelstein","year":"2014","unstructured":"Finkelstein EA, Kruger E. Meta- and cost-effectiveness analysis of commercial weight loss strategies. Obesity. 2014;22(9):1942\u201351.","journal-title":"Obesity"},{"issue":"2","key":"512_CR23","first-page":"279","volume":"101","author":"AM Verreijen","year":"2015","unstructured":"Verreijen AM, et al. A high whey protein-, leucine-, and vitamin D-enriched supplement preserves muscle mass during intentional weight loss in obese older adults: a double-blind randomized controlled trial. Am J ClinNutr. 2015;101(2):279\u201386.","journal-title":"Am J ClinNutr"},{"issue":"2","key":"512_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3945\/jn.114.200832","volume":"145","author":"AJ Hector","year":"2015","unstructured":"Hector AJ, et al. Whey protein supplementation preserves postprandial myofibrillar protein synthesis during short-term energy restriction in overweight and obese adults. J Nutr. 2015;145(2):246\u201352.","journal-title":"J Nutr"},{"issue":"10","key":"512_CR25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.nutres.2014.08.015","volume":"34","author":"A Tahavorgar","year":"2014","unstructured":"Tahavorgar A, et al. Whey protein preloads are more beneficial than soy protein preloads in regulating appetite, calorie intake, anthropometry, and body composition of overweight and obese men. Nutr Res. 2014;34(10):856\u201361.","journal-title":"Nutr Res"},{"issue":"3","key":"512_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S0007114512005314","volume":"110","author":"LE van Meijl","year":"2013","unstructured":"van Meijl LE, Mensink RP. Effects of milk and milk constituents on postprandial lipid and glucose metabolism in overweight and obese men. Br J Nutr. 2013;110(3):413\u20139.","journal-title":"Br J Nutr"},{"issue":"4","key":"512_CR27","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s00394-015-0956-4","volume":"55","author":"S Mehrabani","year":"2016","unstructured":"Mehrabani S, et al. Effects of low-fat milk consumption at breakfast on satiety and short-term energy intake in 10- to 12-year-old obese boys. Eur J Nutr. 2016;55(4):1389\u201396.","journal-title":"Eur J Nutr"},{"issue":"7624","key":"512_CR28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138.","journal-title":"BMJ"},{"key":"512_CR29","unstructured":"A Pocket Guide to Clinical Nutrition. The Parenteral & Enteral Nutrition Group of the British Dietetic Association. 2011."},{"issue":"597","key":"512_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/pgmj.51.597.441","volume":"51","author":"HA Lee","year":"1975","unstructured":"Lee HA, Hartley TF. A method of determining daily nitrogen requirements. Postgrad Med J. 1975;51(597):441\u20135.","journal-title":"Postgrad Med J"},{"issue":"1","key":"512_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","volume":"112","author":"PY Kwo","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. am J Gastroenterol. 2017;112(1):18\u201335.","journal-title":"am J Gastroenterol"},{"key":"512_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/DMSO.S226327","volume":"2020","author":"MF Rafey","year":"2020","unstructured":"Rafey MF, Abdalgwad R, Kilkelly K, Griffin H, Beatty N, O\u2019Shea PM, Collins C, McGrath R, Hynes M, Davenport C, O\u2019Donnell M, Finucane FM. Effects of a milk-based meal replacement program on weight and metabolic characteristics in adults with severe obesity. Diabetes MetabSyndrObes Targets Ther. 2020;2020:197\u2013205.","journal-title":"Diabetes MetabSyndrObes Targets Ther"},{"issue":"5","key":"512_CR33","first-page":"1141","volume":"87","author":"C Gasteyger","year":"2008","unstructured":"Gasteyger C, et al. Effect of a dietary-induced weight loss on liver enzymes in obese subjects. Am J ClinNutr. 2008;87(5):1141\u20137.","journal-title":"Am J ClinNutr"},{"key":"512_CR34","doi-asserted-by":"publisher","first-page":"9796175","DOI":"10.1155\/2019\/9796175","volume":"2019","author":"G Lattuada","year":"2019","unstructured":"Lattuada G, et al. Fasting whole-body energy homeostasis and hepatic energy metabolism in nondiabetic humans with fatty liver. Oxid Med Cell Longev. 2019;2019:9796175.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"512_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ncpendmet0190","volume":"2","author":"M Roden","year":"2006","unstructured":"Roden M. Mechanisms of disease: hepatic steatosis in type 2 diabetes\u2014pathogenesis and clinical relevance. Nat Rev Endocrinol. 2006;2(6):335.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"512_CR36","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G Marchesini","year":"2001","unstructured":"Marchesini G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50(8):1844\u201350.","journal-title":"Diabetes"},{"issue":"3","key":"512_CR37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"JE Lambert","year":"2014","unstructured":"Lambert JE, et al. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology. 2014;146(3):726\u201335.","journal-title":"Gastroenterology"},{"issue":"3","key":"512_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1194\/jlr.P020867","volume":"53","author":"JD Browning","year":"2012","unstructured":"Browning JD, et al. The effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men. J Lipid Res. 2012;53(3):577\u201386.","journal-title":"J Lipid Res"},{"issue":"3","key":"512_CR39","first-page":"267","volume":"38","author":"K Hagopian","year":"2003","unstructured":"Hagopian K, Ramsey JJ, Weindruch R. Caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver. ExpGerontol. 2003;38(3):267\u201378.","journal-title":"ExpGerontol"},{"issue":"3","key":"512_CR40","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"AL Fracanzani","year":"2008","unstructured":"Fracanzani AL, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48(3):792\u20138.","journal-title":"Hepatology"},{"issue":"3","key":"512_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.diabres.2008.05.006","volume":"81","author":"J Yoo","year":"2008","unstructured":"Yoo J, et al. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Diabetes Res ClinPract. 2008;81(3):321\u20136.","journal-title":"Diabetes Res ClinPract"},{"issue":"1","key":"512_CR42","first-page":"21","volume":"11","author":"DA De Luis","year":"2007","unstructured":"De Luis DA, et al. Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase. Eur Rev Med PharmacolSci. 2007;11(1):21\u20135.","journal-title":"Eur Rev Med PharmacolSci"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-020-00512-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-020-00512-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-020-00512-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T02:09:57Z","timestamp":1634350197000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-020-00512-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1186\/s12986-020-00512-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-18620\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-18620\/v2","asserted-by":"object"}]},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"3 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Galway University Hospitals\u2019 Central Research Ethics Committee in December 2017 (ref CA 1900). All participants provided written informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R. Abdalgawad, M.F. Rafey, C. Murphy, I. Ioana, E. Slattery and P. O\u2019Shea declare that they have no competing interests. C. Davenport, D. O\u2019Keeffe and F.M. Finucane have received honoraria, travel grants and have served on advisory boards for Novo Nordisk, Eli Lilly, Ethicon, Pfizer Inc., Sanofi-Aventis, Astra Zeneca, Merck-Serono, Boehringer Ingelheim, Janssen and Novartis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}